Yield10 Bioscience Announces Results of 2019 Field Test Program
March 19, 2020 16:02 ET
|
Yield10 Bioscience, Inc.
-- 2019 Field Test Results Highlight CRISPR Technology Approach to Increase in Oil Content in Oilseed Crops -- Outlines Field Tests Planned for 2020 WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE)...
Yield10 Bioscience Submits "Am I Regulated?" Letter to USDA-APHIS BRS for CRISPR Genome-Edited C3007 in Camelina to Pave the Way for U.S. Field Tests
January 16, 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the...
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Highlight Camelina Platform for Producing PHB Biomaterials to Improve Water Quality at International Scientific Conference
October 04, 2019 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the...
Yield10 Bioscience Announces First Quarter 2019 Financial Results
May 09, 2019 16:05 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the...
Yield10 Bioscience Reports Encouraging Results from 2018 Field Tests of C3003 and Announces Advancement of C3003 into Commercial Development for Canola
January 15, 2019 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global...
Yield10 Bioscience Announces Third Quarter 2018 Financial Results
November 08, 2018 16:02 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global...
Yield10 Bioscience Obtains Nonregulated Status for its Novel CRISPR-Cas9 Triple Gene Edited Camelina Plant Lines to Boost Seed Oil Content
October 02, 2018 08:00 ET
|
Yield10 Bioscience, Inc.
--USDA-APHIS Response Marks Clearance of Yield10’s First Triple Genome-edited Plant Lines --Favorable Response Accelerates Path to U.S. Field Trials in 2019 WOBURN, Mass., Oct. 02, 2018 (GLOBE...